Pregnancy: Clinical experience of intravenous administration of paracetamol is limited. However, a large amount of data from the use of oral therapeutic doses of paracetamol in pregnant women indicate neither malformative, nor feto/neonatal toxicity.
Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically needed, paracetamol can be used during pregnancy however it should be used at the lowest effective dose for the shortest possible time and at the lowest possible frequency.
Breast-feeding: After oral administration, paracetamol is excreted into breast milk in small quantities. No undesirable effects on nursing infants have been reported. Consequently, Paracetamol Kabi may be used in breast-feeding women.
Sign Out